| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1378/CHEST.126.2_SUPPL_1.125S |
| P698 | PubMed publication ID | 15302773 |
| P2093 | author name string | James F Donohue | |
| P433 | issue | 2 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 125S-137S; discussion 159S-161S | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Therapeutic responses in asthma and COPD. Bronchodilators | |
| P478 | volume | 126 |
| Q37253868 | A meta-analysis on the efficacy of oral theophylline in patients with stable COPD. |
| Q34571675 | Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD. |
| Q34521884 | Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial |
| Q36315050 | Aerosol delivery devices and obstructive airway disease |
| Q28067052 | Airflow obstruction: is it asthma or is it COPD? |
| Q41673144 | Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics |
| Q90623036 | Apremilast Normalizes Gene Expression of Inflammatory Mediators in Human Keratinocytes and Reduces Antigen-Induced Atopic Dermatitis in Mice |
| Q46174572 | Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance |
| Q42144426 | Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts |
| Q37044226 | Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies |
| Q39373760 | Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases |
| Q36232072 | Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response |
| Q35747040 | Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD |
| Q35135970 | Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease. |
| Q37070307 | Formoterol in the management of chronic obstructive pulmonary disease. |
| Q35163697 | Helping patients attain and maintain asthma control: reviewing the role of the nurse practitioner |
| Q39317209 | Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease |
| Q34374230 | Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care. |
| Q35201848 | Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry |
| Q37804908 | Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents |
| Q43849764 | Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor. |
| Q38157770 | Pharmacotherapy of critical asthma syndrome: current and emerging therapies |
| Q54196591 | Polymorphisms of beta2-adrenergic receptor gene in serbian asthmatic adults: effects on response to Beta-agonists. |
| Q40829135 | Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure |
| Q35960314 | Screening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation. |
| Q37400972 | Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry. |
| Q38248502 | The acute management of asthma |
| Q64101434 | The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects |
| Q38592062 | The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease |
| Q38095558 | Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease? |
| Q28292569 | ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD? |
Search more.